Forte Biosciences FBRX
FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Operating Leases (2019 - 2020)

Updated

Forte Biosciences' Operating Leases was $3.91 million in Q1 2020, down 59.1% from $9.56 million a year earlier and down 2.9% from the prior quarter.

Analysis

Forte Biosciences (FBRX) Operating Leases (2019 - 2020) Analysis & Trends

At the end of FY2019, Operating Leases at Forte Biosciences came in at $4.03 million.

  • Per Business Quant data, FBRX's Operating Leases in the three quarters before Q1 2020 was $4.03 million (Q4 2019), $9.12 million (Q3 2019) and $9.36 million (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Forte Biosciences 1.58 Bn 1.38 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 3.91 Mn
Dec 31, 2019 4.03 Mn
Sep 30, 2019 9.12 Mn
Jun 30, 2019 9.36 Mn
Mar 31, 2019 9.56 Mn
API Access

Forte Biosciences Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=FBRX&period=max&api_key=YOUR_API_KEY